Medical Cannabis Clinical Trials

3 actively recruiting trials across 1 location

No change since May 2026

Also known as: Cannabis oil containing 10% delta-9-tetrahydrocannabinol (THC) and 5% cannabidiol (CBD)

Pipeline

Phase 2: 2

Top Sponsors

University of Manitoba1
University Medical Center Groningen1
HealthPartners Institute1

Indications

Cancer3
Liver Disease1
Cannabis1
Neurodevelopmental Disorders1
Pancreatic Cancer Non-resectable1

Other2 trials

A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients

Phase 2

Real World Evidence on the Use of Medical Cannabis in Pediatrics

Saint Louis Park, Minnesota1 trial

Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer

HealthPartners Cancer Research Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.